Main Subject - Business

You know that Google has a corner on the market when people refer to pay per click advertising as Adwords campaigns. This is a testimony to the Googl

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e empire. But while Google Adwords may be the biggest game in town they're not the only game in town. Some say there is a good chance that Google may

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

very well be knocked off their thrown. This article is going to look at some problems with Google Adwords that could lead to their downfall. Sometim

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

es, when a company gets big gets too big for their own good, they think that they can do and get away with just about anything. That may hold true fo

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

a while, but anybody who thinks that a giant can't be knocked off its thrown, should take a look at what happened to AT&T and IBM. They are both no

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

onger the monopoly that they once were. And in the case of IBM, they're not even number 1 anymore.

One big consideration with Google pay per click i

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

s that you can no longer send customers to a sales page that isn't yours. Well, you could, but you won't get very far. The search engines can penaliz

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

you heavily if all you're doing is sending people to a landing page of somebody else's product as an affiliate. The reason, they say, is that custom

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

rs would click on ads and each one would take them to the same page. This has driven costs for some keywords through the roof.

A second big consider

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ation is how strictly they hold you to the targeting of keywords and the pages they apply to. This is understandable if you are targeting keywords th

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

t don't at all apply to the pages you are sending customers to, but even if the keywords only slightly applies, they're going to hit you almost as ha

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

d as if the keyword didn't apply at all. Many keywords that you "thought" were perfectly acceptable are now costing 10 to 100 times what your other k

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

eywords are costing.

And finally, Google is not all that easy to use and master. That's the reason why there are so many books written on the subjec

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

. (On a personal note, I have found Chris Carpenters “Google Cash” to be fa

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

and away the best. It’s how I started, and I now make $200-$300 per day.) It takes an awful lot of study to get Google pay per click to work efficie

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ntly. Many people simply don't have that kind of time and ultimately give up on their Google campaigns, especially after they've been slapped. That's

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

a term used to apply to the act of turning your keyword costs into yesterday's filet mignon.

As more and more people consider alternatives because o

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

high click costs, they will slowly turn to the other engines like Yahoo and MSN. Some of these other PPC providers are becoming very viable alternat

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ives. While Google might be the best, they're not the only game in town.

If you are looking for online marketing business opportunity making money t

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

rough Affiliate Marketing, try visiting Squidoo Affiliate Sales.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Main Subject - Google Still King Of Pay Per Click?

Related Articles: